Vectus Biosystems moves to phase 1b in drug trial to treat fibrosis and hypertension

Retrieved on: 2022-09-14 04:18:07

Tags for this article:

Click the tags to see associated articles and topics

Vectus Biosystems moves to phase 1b in drug trial to treat fibrosis and hypertension. View article details on HISWAI: https://smallcaps.com.au/vectus-biosystems-phase-1b-drug-trial-treat-fibrosis-hypertension/

Excerpt

Biotechnology company Vectus Biosystems (ASX: VBS) has announced the ... has covered small and large cap companies listed on the Australian, ...

Article found on: smallcaps.com.au

View Original Article